Investing.com - Valeant (NYSE:VRX)shares jump as pharmaceutical firm names new CFO.
Valeant was up 4.2% in pre-market trade as Paul Herendeen appointed CFO.
The former Zoetis executive will take over from Robert Rosiello immediately.
Rosiello will remain as Valeant executive vice president for corporate development.